Luvox drug
Pro Research Analysisby 
Searched over 200M research papers for "luvox drug"
Luvox (Fluvoxamine) Drug Overview
Indications and Usage for Luvox in OCD Treatment
Luvox (fluvoxamine maleate) is primarily indicated for the treatment of Obsessive-Compulsive Disorder (OCD) in both adults and children aged 8-17 years. OCD is characterized by persistent, intrusive thoughts (obsessions) and repetitive behaviors (compulsions) that the individual feels compelled to perform 1234+6 MORE.
Contraindications and Warnings
Contraindications
Luvox should not be co-administered with terfenadine, astemizole, or cisapride due to the risk of serious cardiac events, including QT prolongation and torsades de pointes-type ventricular tachycardia 1234+6 MORE. Additionally, it is contraindicated in patients with a known hypersensitivity to fluvoxamine maleate 1234+6 MORE.
Warnings
Luvox should not be used in combination with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI treatment due to the risk of serious, sometimes fatal, reactions resembling neuroleptic malignant syndrome 1234+6 MORE. After stopping Luvox, a minimum of two weeks should be allowed before starting an MAOI 1234+6 MORE.
Drug Interactions
Benzodiazepines
Benzodiazepines metabolized by hepatic oxidation, such as alprazolam, midazolam, and triazolam, should be used with caution as fluvoxamine can significantly reduce their clearance, leading to increased plasma concentrations and potential toxicity 1234+6 MORE. For instance, co-administration with alprazolam results in approximately double the plasma concentration, necessitating a reduction in the alprazolam dose by at least half 1234+6 MORE.
Theophylline and Warfarin
Fluvoxamine significantly decreases the clearance of theophylline and warfarin, increasing their plasma concentrations and the risk of adverse effects. Theophylline doses should be reduced to one-third of the usual maintenance dose, and plasma levels should be monitored 1234+6 MORE. Similarly, patients on warfarin should have their prothrombin time monitored, and the warfarin dose adjusted accordingly 1234+6 MORE.
Diazepam
The co-administration of Luvox and diazepam is generally not advisable due to the significant reduction in diazepam clearance, leading to substantial accumulation and potential toxicity 1234+6 MORE.
Precautions
Activation of Mania/Hypomania
During premarketing studies, approximately 1% of patients treated with fluvoxamine experienced hypomania or mania. This risk necessitates cautious use in patients with a history of mania 1234+6 MORE.
Seizures
Seizures were reported in 0.2% of fluvoxamine-treated patients during premarketing studies. Luvox should be used cautiously in patients with a history of seizures and discontinued if seizures occur 1234+6 MORE.
Suicide Risk
The risk of suicide is inherent in patients with depressive symptoms, whether primary or associated with OCD. Close supervision of high-risk patients is essential during initial therapy 1234+6 MORE.
Use in Patients with Concomitant Illness
Clinical experience with Luvox in patients with systemic illnesses is limited. Caution is advised, particularly in patients with liver dysfunction, as fluvoxamine clearance is reduced by approximately 30% in these patients 1234+6 MORE.
Patient Information
Patients should be informed about the potential for impaired cognitive or motor performance and advised to avoid operating hazardous machinery until they are certain that Luvox does not adversely affect their abilities 1234+6 MORE. They should also be advised to avoid alcohol and to notify their physician if they become pregnant, intend to become pregnant, or are breastfeeding 1234+6 MORE.
Conclusion
Luvox is an effective treatment for OCD but requires careful consideration of contraindications, drug interactions, and patient-specific factors to ensure safe and effective use. Close monitoring and patient education are crucial components of therapy with Luvox.
Sources and full results
Most relevant research papers on this topic